Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials

Background: Controversy exists regarding the optimal duration of the extended adjuvant endocrine treatment (ET) in patients with early-stage breast-cancer (eBC).We performed a systematic review and trial-level meta-analysis of all randomized clinical trials (RCTs) comparing a “limited-extended” adju...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Laura Pala, Tommaso De Pas, Eleonora Pagan, Isabella Sala, Chiara Catania, Emma Zattarin, Paolo Arnone, Massimo M. Grassi, Marco Colleoni, Antonio C. Wolff, Javier Cortes, Martine Piccart, Richard D. Gelber, Giuseppe Viale, Vincenzo Bagnardi, Fabio Conforti
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2023-06-01
Saila:	Breast
Gaiak:	Early breast cancer Extended adjuvant endocrine therapy Disease nodal status meta-analysis
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S0960977623000358
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!